The clinical research program at Georgia Cancer Specialists focuses on making targeted cancer therapy accessible to as many patients as possible. With five research sites in Metro Atlanta, Macon, and Athens, patients across the state are able to take part in cutting edge clinical trials targeting all types of cancer, including lung cancer, breast cancer, lymphoma, colon cancer, and prostate cancer.
Because of our strong commitment to research, GCS is affiliated with the Northside Hospital Cancer Institute, one of one of only 21 cancer programs in the United States to be selected by the National Cancer Institute to participate in the NCI Community Cancer Centers Program (NCCCP). As a NCCCP, GCS and the Northside Hospital Cancer Institute will seek to increase patient participation in clinical trials and promote genomically-informed research (also known as personalized medicine).
Through an affiliation with the University of Alabama-Birmingham Comprehensive Cancer Center (UABCCC), GCS is able to offer leading-edge cancer care to GCS patients. GCS is the only private cancer practice in Georgia to offer Level I trials.
Dr. Mansoor Saleh, MD is the director of clinical research at GCS and is also a professor of medicine at UABCCC. He has overseen the research program at GCS for more than a decade and monitors trials from our Northside location. Currently, five other sub-investigators oversee the treatment of all GCS patients on clinical trials. Dr. Aaron Alizadeh, MD and Dr. Simbo Aduloju, MD monitor trials from our Stemmer location, Dr. Cheryl Jones, MD monitors trials from our Macon-Coliseum location, Dr. Rodolfo Bordoni, MD monitors trials from our Kennestone location, and Richard Loyd, DO monitors trial from our Athens location. The research team is comprised of physicians and specialized clinical staff trained in research design, data collection, and analysis.